review · BMC Infectious Diseases
BACKGROUND: Despite significant efforts to enhance access to antiretroviral therapy (ART), opportunistic infections among children on ART remain a major concern in low-income countries, including Ethiopia. Currently, there are no pooled estimates of opportunistic infections incidence among children on ART in Ethiopia. Consequently, this review aimed to determine the pooled incidence and identify the predictors of opportunistic infections among children under 15 years of age on ART, addressing the existing information gap. METHODS: statistic, and publication bias was assessed through funnel plots and Egger's test. RESULTS: Of the 5,631 studies identified, 20 studies involving 9,196 participants were included in the meta-analysis. The pooled incidence of opportunistic infections among children under 15 years of age on antiretroviral therapy was 5.61 per 100 person-years (95% CI: 4.37-6.86), based on 36,716.4 person-years of observation. Predictors of opportunistic infections included advanced WHO clinical stage (HR 1.45, 95% CI: 1.35-1.55), poor ART adherence (HR 1.49, 95% CI: 1.35-1.63), lack of isoniazid (HR 1.56, 95% CI: 1.40-1.74) and cotrimoxazole preventive therapy (HR 1.56, 95% CI: 1.38-1.66), malnutrition (HR 1.50, 95% CI: 1.34-1.67), and severe immunosuppression (HR 1.39, 95% CI: 1.27-1.51). CONCLUSION: The incidence of opportunistic infections in this review was high, highlighting the need for intensified efforts to achieve the 2030 target. Moreover, advanced WHO clinical stage, poor adherence, lack of isoniazid and cotrimoxazole preventive therapy, malnutrition, and severe immunosuppression were identified as predictors of opportunistic infections. This suggests that early initiation of ART, regular nutritional assessments, intensive follow-up and monitoring, and a multidisciplinary approach need be prioritized to address the identified predictors.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s12879-025-10945-z
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.